This is a preview of subscription content, log in via an institution to check access.
Reference
van der Veen SJ, et al. Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression. Molecular Genetics and Metabolism 135: 163-169, No. 2, Feb 2022. Available from: URL: http://doi.org/10.1016/j.ymgme.2021.12.004
Rights and permissions
About this article
Cite this article
Agalsidase-beta. Reactions Weekly 1908, 25 (2022). https://doi.org/10.1007/s40278-022-15753-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-15753-5